Results 261 to 270 of about 127,194 (360)

Norepinephrine Neurons in the Nucleus of the Solitary Tract Suppress Luteinizing Hormone Secretion in Female Mice. [PDF]

J Neurosci
McCosh RB, Kreisman MJ, Tian K, Thomas SA, Breen KM.   +4 more
europepmc   +1 more source

High‐Dose Hormone Replacement Therapy Improved Embryo Transfer Outcomes in a Woman With 21‐Hydroxylase Deficiency Who Had Persistently High Serum Progesterone Levels: A Case Report and Literature Review

Clinical Case Reports, Volume 13, Issue 10, October 2025.
Pathology of endometrial dating in women with 21‐OHD under HRT. ABSTRACT Women with 21‐hydroxylase deficiency have reduced fertility because of excessive production of adrenal androgen and progesterone, which can inhibit folliculogenesis, disturb the normal gonadotropin secretion pattern and development of the endometrium, and affect endometrial ...
Yuri Mizusawa, Hiroaki Shibahara, Masahide Shiotani   +2 more
wiley   +1 more source

Effect of progesterone sequential therapy on follicle stimulating hormone (FSH), luteinizing hormone (LH), and estradiol (E2) in perimenopausal dysfunctional uterine bleeding. [PDF]

J Med Biochem
Wu S, Wang H, Zhao Y, Tang B, Zhang Q, Li D.   +5 more
europepmc   +1 more source

Effects of Luteinizing Hormone Releasing Hormone (LHRH) upon Bioactive and Immunoreactive Serum LH Levels in Normal Subjects

, 1976
Maria Dufau, Inese Z. Beitins, Janet W. McArthur, Kevin Catt   +3 more
openalex   +1 more source

Efficacy and Safety of Combination Androgen‐Receptor Signaling Inhibitors, Denosumab, and Local Radiotherapy for Poly‐Metastatic Prostate Cancer

Cancer Reports, Volume 8, Issue 10, October 2025.
ABSTRACT Background The Treatment of Metastatic Castration‐Sensitive Prostate Cancer (mCSPC) has dramatically changed over the past decade. To improve oncological outcomes, pharmacological treatments have evolved to include two‐or three‐drug combinations, and the efficacy of local radiation therapy (LRT) at the prostate combined with denosumab ...
Makoto Kawase, Kota Kawase, Yuki Tobisawa, Koji Iinuma, Keita Nakane, Takuya Koie   +5 more
wiley   +1 more source

Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus. [PDF]

Front Reprod Health
Salehpour S, Aleyasin A, Moini A, Mousavifar N, Mohammadhossein N, Abdollahi Fard S, Marzie S, Mohammadzadeh M, Fischer R.   +8 more
europepmc   +1 more source

IN VITRO RELEASE OF LUTEINIZING HORMONE-RELEASING HORMONE (LHRH) FROM RAT MEDIOBASAL HYPOTHALAMUS: EFFECTS OF POTASSIUM, CALCIUM AND DOPAMINE.

, 1976
W.H. Rotsztejn, Jean‐Louis Charli, E. Pattou, Jacques Epelbaum, Claude Kordon   +4 more
openalex   +1 more source

The Type of Follicle‐Stimulating Hormone Medication Given for In Vitro Fertilization Impacts Oocyte Retrieval: A Systematic Review and Meta‐Analysis

Clinical Pharmacology &Therapeutics, Volume 118, Issue 4, Page 790-802, October 2025.
Understanding the variability in ovarian response following administration of follicle‐stimulating hormone medications in women undergoing in vitro fertilization may help inform prescribing decisions. A systematic review was conducted to compare the number of retrieved oocytes and fertility outcomes following the administration of different follicle ...
Toni J.F. Michael, Ranita Kirubakaran, Tanay Parab, Rui Wang, Mark Grosser, Beverley J. Vollenhoven, Vinayak Smith, Sophie L. Stocker, on behalf of the LIFE Consortium, Beverley Vollenhoven, Franca Agresta, Mian Bi, Emanuel Birru, David Coman, Nicholas Devereaux, David Gardner, Mark Grosser, Grant Hatamosa, Fabrizzio Horta, Hua Lin, David Listijono, Gavin Sacks, Vinayak Smith, Kate Stern, Sophie Stocker, Steven Tipper, Deon Venter, Rui Wang   +27 more
wiley   +1 more source

Luteinizing hormone is independently associated with high-sensitive cardiac troponin T elevation in postmenopausal T2DM patients: A cross-sectional study. [PDF]

J Diabetes
Wang Y, Li Y, Liu C, Wang Y, Li Y.
europepmc   +1 more source

The Ontogenesis of Human Fetal Hormones. IV. Somatostatin, Luteinizing Hormone Releasing Factor, and Thyrotropin Releasing Factor in Hypothalamus and Cerebral Cortex of Human Fetuses 10-22 Weeks of Age

, 1977
Michel L. Aubert, Melvin M. Grumbach, Selna L. Kaplan   +2 more
openalex   +1 more source